Business Atossa Therapeutics Advances Metastatic Breast Cancer Treatment Atossa Therapeutics, Inc. has received a “Study May Proceed” letter from the U.S. Food and Drug Administration (FDA) for its investigational new drug application... Editorial6 January, 2026